Ignite Creation Date:
2025-12-25 @ 2:33 AM
Ignite Modification Date:
2026-07-16 @ 9:57 AM
Study NCT ID:
NCT00121134
Status:
COMPLETED
Last Update Posted:
2013-12-24
First Post:
2005-07-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer
Sponsor:
Harold J. Burstein, MD, PhD
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Breast Cancer | View |